Mineralys Therapeutics, Inc. · NASDAQ:MLYS
Adams Street Partners LLC's stake in Mineralys Therapeutics, Inc. fell to 2.30% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Adams Street Partners LLC's stake in Mineralys Therapeutics, Inc. fell to 2.30%, 1,129,807 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 2.30%
- Shares
- 1,129,807
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 8 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Adams Street Partners, LLC | 2.30% | 1,129,807 |
| Adams Street 2016 Direct Venture/Growth Fund LP | 0.20% | 91,126 |
| Adams Street 2017 Direct Venture/Growth Fund LP | 0.20% | 117,878 |
| Adams Street 2018 Direct Venture/Growth Fund LP | 0.40% | 176,038 |
| Adams Street 2019 Direct Growth Equity Fund LP | 0.20% | 98,889 |
| Adams Street 2020 Direct Growth Equity Fund LP | 0.20% | 105,448 |
| Adams Street 2021 Direct Growth Equity Fund LP | 0.20% | 102,305 |
| Adams Street Growth Equity Fund VII LP | 0.90% | 438,123 |